BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12240255)

  • 1. 3'-amino-2',4'-BNA: novel bridged nucleic acids having an N3'-->P5' phosphoramidate linkage.
    Obika S; Onoda M; Morita K; Andoh J; Koizumi M; Imanishi T
    Chem Commun (Camb); 2001 Oct; (19):1992-3. PubMed ID: 12240255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and properties of a novel bridged nucleic acid with a P3' --> N5' phosphoramidate linkage, 5'-amino-2',4'-BNA.
    Obika S; Nakagawa O; Hiroto A; Hari Y; Imanishi T
    Chem Commun (Camb); 2003 Sep; (17):2202-3. PubMed ID: 13678201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and properties of 3'-amino-2',4'-BNA, a bridged nucleic acid with a N3'-->P5' phosphoramidate linkage.
    Obika S; Rahman SM; Song B; Onoda M; Koizumi M; Morita K; Imanishi T
    Bioorg Med Chem; 2008 Oct; 16(20):9230-7. PubMed ID: 18812260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel nucleic acid analogue, 3'-amino-2'-deoxy-3',4'-BNA, with an N3'-->P5' phosphoramidate linkage and an S-type conformation.
    Nakagawa O; Hiroto A; Obika S; Imanishi T
    Nucleic Acids Res Suppl; 2003; (3):87-8. PubMed ID: 14510393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligonucleotide n3'-->p5' phosphoramidates and thio-phoshoramidates as potential therapeutic agents.
    Gryaznov SM
    Chem Biodivers; 2010 Mar; 7(3):477-93. PubMed ID: 20232321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and properties of 2',4'-BNA(NC), a second generation BNA.
    Rahman SM; Seki S; Utsuki K; Obika S; Miyashita K; Imanishi T
    Nucleic Acids Symp Ser (Oxf); 2005; (49):5-6. PubMed ID: 17150605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and properties of 2',4'-BNA(NC): a bridged nucleic acid analogue.
    Rahman SM; Seki S; Obika S; Yoshikawa H; Miyashita K; Imanishi T
    J Am Chem Soc; 2008 Apr; 130(14):4886-96. PubMed ID: 18341342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligonucleotide N3'-->P5' phosphoramidates.
    Gryaznov SM; Lloyd DH; Chen JK; Schultz RG; DeDionisio LA; Ratmeyer L; Wilson WD
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5798-802. PubMed ID: 7541136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. alpha-Oligodeoxyribonucleotide N3'-->P5' phosphoramidates: synthesis and duplex formation.
    Pongracz K; Gryaznov SM
    Nucleic Acids Res; 1998 Feb; 26(4):1099-106. PubMed ID: 9461474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermodynamic and kinetic effects of N3'-->P5' phosphoramidate modification on pyrimidine motif triplex DNA formation.
    Torigoe H
    Biochemistry; 2001 Jan; 40(4):1063-9. PubMed ID: 11170429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and properties of a novel bridged nucleic acid analogue bearing a P3'-->N5' phosphoroamidate linkage, 5'-amino-3', 5'-BNA.
    Sekiguchi M; Obika S; Somjing R; Imanishi T
    Nucleic Acids Symp Ser (Oxf); 2004; (48):7-8. PubMed ID: 17150451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic stabilization of nucleic acid assembly by oligo-N3'-->P5' phosphoramidate modification and additions of comb-type cationic copolymers.
    Torigoe H; Maruyama A
    J Am Chem Soc; 2005 Feb; 127(6):1705-10. PubMed ID: 15701004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA polymerase activity on synthetic N3'→P5' phosphoramidate DNA templates.
    Lelyveld VS; O'Flaherty DK; Zhou L; Izgu EC; Szostak JW
    Nucleic Acids Res; 2019 Sep; 47(17):8941-8949. PubMed ID: 31428779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and duplex-forming ability of oligonucleotides modified with 4'-C,5'-C-methylene-bridged nucleic acid (4',5'-BNA).
    Yamaguchi T; Yamamoto C; Horiba M; Aoyama H; Obika S
    Bioorg Med Chem; 2021 Sep; 46():116359. PubMed ID: 34391942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promotion of triplex formation by N3'-->P5' phosphoramidate modification: thermodynamic and kinetic studies.
    Torigoe H
    Nucleic Acids Res Suppl; 2001; (1):57-8. PubMed ID: 12836262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic oligonucleotides as RNA mimetics: 2'-modified Rnas and N3'-->P5' phosphoramidates.
    Egli M; Gryaznov SM
    Cell Mol Life Sci; 2000 Sep; 57(10):1440-56. PubMed ID: 11078022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A bridged nucleic acid, 2',4'-BNA COC: synthesis of fully modified oligonucleotides bearing thymine, 5-methylcytosine, adenine and guanine 2',4'-BNA COC monomers and RNA-selective nucleic-acid recognition.
    Mitsuoka Y; Kodama T; Ohnishi R; Hari Y; Imanishi T; Obika S
    Nucleic Acids Res; 2009 Mar; 37(4):1225-38. PubMed ID: 19136459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligonucleotide N3'-->P5' phosphoramidates as potential therapeutic agents.
    Gryaznov SM
    Biochim Biophys Acta; 1999 Dec; 1489(1):131-40. PubMed ID: 10807003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA mimetics: oligoribonucleotide N3'-->P5' phosphoramidates.
    Gryaznov SM; Winter H
    Nucleic Acids Res; 1998 Sep; 26(18):4160-7. PubMed ID: 9722635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and properties of 5'-amino-2',4'-BNA modified oligonucleotides with P3'-->N5' phosphoramidate linkages.
    Obika S; Nakagawa O; Hiroto A; Hari Y; Imanishi T
    Nucleic Acids Res Suppl; 2002; (2):25-6. PubMed ID: 12903087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.